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Background Missing data frequently create problems in the analysis of population-based data sets, such as those collected by cancer registries.
Restriction of analysis to records with complete data may yield inferences that are substantially different from those that would have been obtained had no data been missing. 'Naive' methods for handling missing data, such as restriction of the analysis to complete records or creation of a 'missing' category, have drawbacks that can invalidate the conclusions from the analysis. We offer a tutorial on modern methods for handling missing data in relative survival analysis.
Methods
We estimated relative survival for 29 563 colorectal cancer patients who were diagnosed between 1997 and 2004 and registered in the North West Cancer Intelligence Service. The method of multiple imputation (MI) was applied to account for the common example of incomplete stage at diagnosis, under the missing at random (MAR) assumption. Multivariable regression with a generalized linear model and Poisson error structure was then used to estimate the excess hazard of death of the colorectal cancer patients, over and above the background mortality, adjusting for significant predictors of mortality.
Results
Incomplete information on stage, morphology and grade meant that only 55% of the data could be included in the 'complete-case' analysis. All cases could be included after indicator method (IM) or MI method. Handling missing data by MI produced a significantly lower estimate of the excess mortality for stage, morphology and grade, with the largest reductions occurring for late-stage and high-grade tumours, when compared with the results of complete-case analysis.
Conclusion
In complete-case analysis, almost 50% of the information could not be included, and with the IM, all records with missing values for stage were combined into a single 'missing' category. We show that MI methods greatly improved the results by exploiting all the information in the incomplete records. This method also helped to ensure efficient inferences about survival were made from the multivariate regression analyses.
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Introduction
Participants in our courses on cancer survival analysis often ask for a written account of how to handle data with missing values. This short tutorial is an attempt to meet that demand. We discuss why it is important to resolve missing data, present some of the methods for doing so and provide a worked example of our preferred method, using real data. Incomplete data are unavoidable in most research studies, even if great efforts are made in planning and data collection. Incomplete data are often more prevalent in population-based data, such as those collected by cancer registries. A variety of ad hoc approaches for handling missing data have been explored over the past 30 years, and their impact on the results of the analyses and the conclusions that can be drawn has been examined. [1] [2] [3] [4] Such methods include 'complete-case' analysis, in which only cases with complete data for the variables of interest are included in the analysis, 'mean-substitution', in which the average value in the data set is used to replace a missing value and the use of a separate category for patients with missing data. All these methods have drawbacks, including arbitrariness, loss of power and bias.
Imputation, the practice of 'filling in' the missing values in the data, is an attractive approach for analysing incomplete data. It effectively resolves the missing-data problem before the analysis is done. Each missing observation is assigned an imputed value, thus creating a 'completed' dataset that has no missing values. The 'completed' dataset, made up of both the observed and the imputed data, is then analysed with standard statistical methods. However, a 'naive' or unprincipled imputation method will usually result in distortion of the estimates and their standard errors, and of hypothesis tests. [5] [6] [7] [8] [9] [10] [11] In this tutorial, we apply the multiple imputation (MI) method to a colorectal cancer data set to handle the incompleteness of tumour information. The aim was to provide more robust estimates of the excess hazard ratio (EHR) of death, relative to a baseline category, while adjusting for confounders such as stage at diagnosis, sex, age, socio-economic deprivation, anatomic site, morphology, tumour grade and comorbidity. For several of these variables, the raw data were incomplete. MI is essentially a two-stage (Monte-Carlo) stochastic method for parameter estimation in the presence of missing data. The performance of MI in regression analysis of relative survival estimates with incomplete data on covariates has been assessed in a recent simulation study. The authors concluded that the technique performs adequately when the missing data are missing at random (MAR). 12 We show that MI under this assumption is feasible with currently available software. We argue that the resulting inferences are more plausible than those obtained with other approaches, and we advocate more widespread use of MI for the estimation of cancer survival with data sets containing incomplete tumour records.
Methods
Cancer registry data Population-based cancer registries collect data on all patients diagnosed with cancer in the resident population of their territory, with high levels of data completeness for many variables. Despite recent improvements in the completeness of data collection, however, through case-note extraction and linkage to external datasets (screening, specialized cancer datasets, hospital discharges), completeness is often much lower for key variables such as tumour stage and treatment. Stage at diagnosis is a very strong predictor of outcome for colorectal cancer, with 5-year relative survival 490% for stage I disease, falling to 20% for stage IV. 13 Information on tumour stage is more often incomplete in patients with late-stage tumours and poor survival, possibly because invasive investigations to determine the tumour stage precisely may be judged less clinically relevant for patients who will only receive palliative treatment. As a result, limiting survival analysis to patients with complete data on the stage of disease at diagnosis could introduce bias and lead to incorrect conclusions. 14 Survival analyses have been published for other cancers after MI of missing stage, [14] [15] [16] and on relative survival for colorectal cancer 17 and breast cancer. 18 These studies had similar levels of incompleteness, but included fewer details on treatment and comorbidity. 19 
Survival
Relative survival has become the 'gold standard' method for estimating cancer survival in populationbased data. Relative survival is the ratio of the observed probability of survival (S) of the cancer patients and the probability of survival that would have been expected (E) if the patients had had the same survival probability as in the general population: 20 RðtÞ ¼ SðtÞ EðtÞ ð1Þ
where R, S and E are the relative, observed and expected survival probabilities, respectively, at time t. The expected survival is derived from the general population (background) mortality, using life tables stratified by age, sex and calendar period.
The background risk of death may also vary with factors such as geographic region or socio-economic status, and such variables may be included in specific life tables. Although the life tables include deaths due to cancer, this has little or no impact on the estimated background risks of death. [21] [22] [23] The excess mortality in the cancer population is that component of the risk of death in excess of the background risk. Regression models for relative survival are the most effective method of assessing the impact of multiple factors on survival. 24 Various approaches have been used to model relative survival. Most are based on the underlying additive hazards model. 23 l ðxÞ ¼ l Ã ðxÞ þ expðxÞ ð 2Þ
where lðxÞ is the observed hazard for patients diagnosed with cancer, l Ã ðxÞ the expected hazard function, estimated from external data (life tables), x a vector of covariates, the log of the excess hazard and expðxÞ the EHR. The EHR estimated by such models can be thought of as the probability of dying from the cancer in the presence of the factor x divided by that probability in the absence of the factor x. It is equivalent to a risk ratio after subtraction of the background hazard.
Mechanisms of missing data
The most appropriate way to handle missing data depends on why the data are missing (the mechanism) and on the associations of the missing data. Rubin 6, 25 defines three types of missing data mechanisms: missing completely at random (MCAR), MAR and missing not at random (MNAR). MCAR occurs when the probability of an observation being missing is completely random, that is, it does not depend on explanatory variables and/or on outcome. In this situation, cases with missing data can be excluded from the analysis and valid inferences can still be made, although this will result in some loss of statistical power. 26 A typical example of MCAR arises when stage and age are variables of interest, and the probability of stage being recorded in the data is independent of the actual stage at diagnosis, or the patient's age or vital status.
The mechanism of missingness is said to be MAR when cases with incomplete data differ from cases with complete data, but the chance of data being missing is independent of the unseen values, given other observed variables and/or outcomes in the database. For example, this could arise if stage data are missing for some patients, but the chance that stage data are missing is both independent of the (missing) value for stage and fully explained by age (where age is a variable with no missing data).
When, even given the observed data, the chance of a value being missing still depends on the unseen value, the missing data mechanism is referred to as MNAR.
Unlike the various ad hoc approaches for handling missing data, which assume MCAR as the mechanism of missing data, more advanced approaches, such as MI by chained equations (MICE), make the more reasonable assumption (especially if we have variables predictive both of values being missing and of the underlying unseen values) 27 that the data are missing at random. This simplifies the analysis, because the missing data mechanism does not have to be explicitly modelled.
Indicator method
The indicator method is a simple idea developed before the new generation of fast computers. 28, 29 This method was first used in regression analysis, in which a missing value category is created for each incomplete, independent, categorical variable. The indicator takes the value 1 if the value is missing for that variable, and 0 otherwise. For example, suppose the variable X i , cancer staging, is a variable with four categories, and some of its values are missing.
The missing values of the variable in a regression analysis are replaced by
is missing and 0 otherwise. This is similar to creating an additional category for missing values. This method was widely used by epidemiologists for handling missing data because of its simplicity, but it was found to produce biased estimates under most conditions, 1, 28 and could lead to ambiguous results because very dissimilar classes might be lumped into one category.
Multiple imputation
When the cases with incomplete data comprise only a small fraction of all cases (say, 45%), restriction of the analysis to records with no missing values ('complete-case' analysis), may be a reasonable solution in cancer research. The major disadvantage is that this approach assumes the missing data mechanism to be MCAR, a strong assumption that is not realistic in most datasets.
Other approaches are valid under the MAR assumption, such as model-based methods or MI. Among the model-based methods, the Expectation-Maximization (EM) algorithm 30 fits a specific model by maximizing the likelihood of the observed data, having integrated the likelihood over the missing data. The EM algorithm has to be specified for each model fitted: this can be complex, and the standard errors are relatively difficult to obtain. These drawbacks and the absence of robust, accessible software make this approach difficult for non-statisticians. 26 In contrast, MI is both simpler and more intuitive. Under the MAR assumption, we draw plausible values for the variable with missing data from the distribution of that variable given the observed data for other variables. We refer to the model for this distribution as the imputation model. We construct a 'completed' dataset by putting the imputed data together with the observed data. We create m completed data sets in this way. When we fit our scientific model to each of the completed data sets in turn, we obtain a set of m estimates for the parameter of interest. The mean of the m estimates for the parameter is corrected for the fact that observations with no missing data may be a biased sample, whereas its variance correctly captures the extra uncertainty due to the missing data.
Readily available software enables the user (i) to fit the imputation model, (ii) to fill in the missing values under that model, (iii) to fit the scientific model of interest to the 'completed' data sets and, finally, (iv) to combine the estimates. MI is therefore a practical tool that addresses potentially serious bias due to systematic differences in outcome between the observed and unobserved data, at least under the MAR assumption.
In more detail, we apply MICE, 11 a technique closely related to Gibbs sampling. 31 This is an iterative technique that deals with missing values when more than one variable is incomplete. The method assumes that a multivariate joint distribution for the data exists, without specifying a specific form for it, then generates samples from it by Gibbs sampling of the conditional distributions. Suppose that variables x 1 and x 2 are incomplete, and the remaining variables x 3 , . . . , x k are fully observed (no missing values). The method proceeds as follows. (xi) Combine the survival estimates from the 'completed' datasets to obtain the mean of the estimated log EHR ¼ ð1=mÞ P m j¼1 j . The variance is estimated from two components:
(1) within-imputation variance:
U
The overall standard error is the square root of T. The confidence intervals (CIs) are calculated by taking the average estimate plus or minus a number of standard errors:
where that number is a quantile of a t-distribution with degrees of freedom given by:
We use the MIM software in Stata (MIM) 32 to fit the scientific model of interest to each imputed data set and combine the results, as described above.
Data
All adults (aged 15-99 years) resident in the North West of England who were registered in the North West Cancer Intelligence Service with a first, primary, malignant, invasive colorectal cancer (ICD-10 C18-C20) diagnosed during 1997-2004 were eligible for analysis. A total of 29 563 records were linked to Hospital Episode Statistics (HES) 33 data on comorbidity and treatment. For each patient, the Charlson comorbidity index 34, 35 was derived for comorbid conditions occurring in the period 6-18 months before the diagnosis of colorectal cancer.
Imputation of missing data and statistical analysis For each incomplete variable (stage, morphology and grade), we derived imputation models that included the other two incomplete variables, as well as the complete variables (sex, age, deprivation, comorbidity, treatment and colorectal site), outcome (vital status and follow-up time in years) and two interactions: those between deprivation and follow-up time, and between age and follow-up time. For the purposes of imputation, follow-up time was categorized in two intervals of 6 months in the first year, then yearly up to 5 years and then a single interval for 5 years and later. Ordinal regression models were chosen for stage and grade, and a polytomous regression for morphology. A total of 10 'completed' data sets were constructed. We used the maximum likelihood approach for individual records 36 to estimate relative survival in each of the 10 datasets, using life tables for the North West Government Office Region that were specific for each of five deprivation categories. Survival probabilities were estimated monthly for the first year, then quarterly up to 3 years, then six-monthly up to 5 years. Multivariable regression using a generalized linear model with Poisson error 23 was then used to estimate the EHR of death adjusting for socio-demographic and clinical variables. Interaction between these variables and follow-up time was investigated. Since short-term and long-term EHRs were significantly different for age at diagnosis (P ¼ 0.0047) and deprivation (P < 0.001), we present the estimates separately for the first year after diagnosis and from the first anniversary to 5 years after diagnosis. The same multivariable regression analysis was repeated with a separate category created for missing stage, morphology and grade. All analyses were carried out in STATA 10.0. 37 The Stata code described in this tutorial is freely accessible from the Cancer Survival Group Website (http://www.lshtm.ac.uk/ncdeu/cancersurvival/tools/index.htm) and the missing data website (www.missingdata.org.uk)
Results
For substantial proportions of the 29 563 adults with colorectal cancer, data were missing on stage of disease at diagnosis (11 684, 40%), morphology (3428, 12%) or grade (7397, 25%) ( Table 1) . Data on stage were missing more often for women than men and for patients with rectal as opposed to colon cancer. The probability of data being missing was positively associated with increasing age, increasing deprivation and non-surgical treatment (Table 1) . Strong associations between missing data and both vital status and time to death were seen. For example, patients with missing stage were as likely as those with stage IV to die within the first year after diagnosis, but the pattern was more like patients with stage II in the second to fifth year since diagnosis (data not shown). Patients who were not recorded as having received any treatment were most likely to have missing data on stage (88%). Information on stage, morphology and grade was all derived from pathology reports, and in 3059 (10%) patients, data were missing for all three variables. Patients with missing data on stage were more likely to be assigned to advanced stage (III or IV) after imputation, and adenocarcinoma was the most common morphologic type both before (80.1%) and after imputation (90.5%). No change was observed in the distribution of grade after imputation.
Because of the absence of data on stage, morphology and grade, only 55% of patients (16 223) could be included in the analyses when we adopted the 'complete-case' approach (Table 2) . By contrast, all the cases could be included in survival analysis after use of either the indicator method or MI to deal with missing data. Figure 1 shows relative survival by time, before and after MI for missing data. Survival curves for stages I and II are similar, whereas stages III and IV show a markedly different early hazard. For example, before imputation, relative survival is $80% for stage III and 40% for stage IV; once we have included the imputed information from patients with missing data on stage using MI, these values drop to $60 and 30%, respectively.
The EHRs for categories of both stage and grade were broadly similar with all three approaches to handling missing data, although the EHR for stage IV was higher with the complete-case method and indicator method (26.39 and 19.12 , respectively) than the 16.53 obtained with MI.
The EHR for death within the first year after diagnosis increased more steeply across categories of age at diagnosis after MI (EHR 5.41 for patients aged 85-99 years) than with the other methods for handling Colorectal site (ICD-10 code) Colon (C18) missing data. The EHR for death between the first and fifth anniversaries of diagnosis also rose steadily with age after MI (EHR 1.53 for patients aged 85-99 years). This pattern was either absent or not monotonic with the other approaches ( Table 2 ). The EHR of death within the first year of diagnosis also increased more steeply across the five categories of deprivation after MI (EHR 1.37 for the most deprived) than with complete-case analysis (EHR 1.29). No such pattern was discernible for the EHR for death between the first and fifth anniversaries of diagnosis.
Discussion
High levels of incompleteness in population-based cancer registry data complicate the analysis and the interpretation of predictors of the excess hazard of death, and they limit the inferences that can be made. This issue is particularly important for strong predictors like stage at diagnosis, 13, 38 which is often missing for a large proportion of cancer cases.
Incompleteness of stage is a key issue in populationbased cancer survival, but similar measures of prognosis may be relevant for other disease groups (e.g. CD4 count for HIV/AIDS or cholesterol level for heart disease). Our study shows that patients who did not have surgery were more likely to have late-stage tumours or comorbid conditions, and more likely to have missing data on stage, morphology and grade. The close association of missing data for these variables makes it difficult, or impossible, to compare survival adjusted for case mix and to evaluate improvement in late-stage patients.
The multivariable excess hazard model applied to the 16 223 colorectal cancer records with complete data (55% of the study population) suggested that stage at diagnosis, colorectal site and old age were strong predictors of the excess hazard of death. The main assumption in this approach is that the reason data are missing is not related either to other covariates or to the outcome. However, there was evidence that missing stage was associated with other observed variables, such as age at diagnosis and treatment. The excess hazard of death estimated from analysis of records with complete data is therefore likely to be biased, because missingness of stage was not completely at random. It is also less precise because of the substantial reduction in the number of records analysed. In effect, all information from individuals with as few as one missing observation is lost. In the indicator method, a large proportion of patients were in the 'missing' categories for which we obtained highly significant but ambiguous EHR estimates. For example, it is clearly unsatisfactory to combine all patients for whom there are no data on stage into a single group, when those patients are in fact distributed across all stage categories. The indicator method had a higher precision than the complete-case analysis because a record was included for every individual in the dataset. This method underestimates the uncertainty caused by the missing data: in effect, we pretend that we have more confidence in the missing values than the observed values. However, both approaches missed the increasing short-term and long-term excess mortality associated with older ages at diagnosis.
The information on stage, morphology and grade 'completed' by imputation increased the EHR for the already complete age group, deprivation and comorbidity by adjusting for their confounding effect more effectively. Inclusion of information from individuals with only partial data in the MI method provides estimates with higher precision than those obtained from complete-case analysis. Under the MAR assumption, theory shows that the narrower CIs will still have the correct coverage. 7 The major advantage of MI is the analysis that would have been applied if the original data had been complete can be performed on each 'completed' data set without modification of the programs. All information in the incomplete records is included, and 'completed' data sets can later be used for semi-automatic subsequent analysis. MI also allows the calculation of standard errors through a relatively simple and very general procedure. This procedure has no direct counterpart if the EM algorithm is used to obtain point estimates.
In the context of population-based cancer data, a major advantage of MI over both the EM algorithm and the IM is the availability within standard statistical packages of software to perform the imputation. In each of the 10 datasets completed by MI, relative survival was estimated with readily available free software 39, 40 written in STATA. 37 Software is also available to analyse 39 and combine 41 the 10 estimates of the excess hazard of death of the colorectal cancer patients over the background mortality, using a generalized linear model with Poisson error. Software to generate multiple imputed datasets and estimate and model the excess hazard of death is also available in the IVEWare package for SAS 42 software, and similar packages exist for R and S-Plus. As far as we are aware, however, neither R nor S-Plus currently have programs for estimating relative survival. The methodology and the software described here are transferable for use with other variables of missing data or other population-based datasets, whether for cancer or other conditions, for which relative survival may be utilized.
The estimation of relative survival from individual patient records yields several observations for each individual in the dataset, because there is a record for each subdivision of time. MI to resolve missing data in such large datasets may be computationally demanding. However, this is also true for other approaches to handling missing data: the EM algorithm may also be extremely slow if a lot of data are missing 5, 43 and, in some cases, it may be difficult to judge whether convergence has occurred.
The complete-case analysis provides useful information to identify predictors of the excess hazard of death in our final analysis model. 26 It is also important to understand associations between incomplete variables and fully observed variables to ensure that all relevant covariates are included in the imputation model. 11 Imputation models should include at least all the variables that will be included in the analysis model, together with any interactions. Further predictors of missingness in the dataset that are associated with variables in the scientific model should also be included in the imputation model. Also, survival time and vital status (dead: yes or no), although they can be considered as outcome variables, are strong predictors of missingness, and were included in the imputation models. 44 Lastly, it is important to notice that the MAR assumption can never be directly validated. However, including as many predictors as possible in the imputation model tends to make the assumption of MAR more reasonable. 45 Sensitivity analyses can be done to examine the effect on the estimates and standard errors of changing the assumptions for the mechanism causing the missing data. 9 Again, MI provides a natural framework for doing this. 9, 46 We intend to address this in a subsequent article.
In summary, we argue that in population-based data, the 'MAR' assumption is a good first approximation for the mechanism of missing data. We also demonstrate the practical utility of MI to complete missing values in the data before the estimation of relative survival. We recommend that authors follow recently proposed guidelines 27 when using MI to prepare data with missing values for subsequent analysis.
It will often be helpful to report the results of complete-case analysis as well. This allows explanation of why the results differ from those derived from MI, the preferred method. 
